Maria J. Ramalho
Rua Dr. Roberto Frias
Porto, 4200465, Portugal
Porto, 4200465, Portugal
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 36 publications
Advances in Strategies to Transport Nanoparticles Across the Blood-Brain Barrier for Drug Delivery into the Brain for the Treatment of Alzheimer's Disease.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: March 30, 2026
Lactoferrin-Decorated PLGA Nanoparticles for Targeted Tamoxifen Repurposing in Glioblastoma Cells.
Journal: Polymers
Published: March 23, 2026
Surface-Modified Polymeric Nanoparticles for Glioblastoma Therapy: A Review on Targeting Strategies and Delivery of Repurposed Drugs and Off-Label Non-Alkylating Agents.
Journal: Pharmaceutics
Published: March 09, 2026
Targeted liposomal epigallocatechin delivery for Alzheimer's disease: Effect on amyloid β fibrillation and neutralization of free radicals.
Journal: International journal of biological macromolecules
Published: March 04, 2026
Solid lipid nanoparticles as carriers for Ulva rigida peptide extract with demonstrated anti-β-amyloid and antioxidant properties.
Journal: Frontiers in aging neuroscience
Published: December 30, 2025
PLGA Nanoparticles Double-Decorated with a TAT Peptide and Folic Acid to Target Staphylococcus aureus.
Journal: International journal of molecular sciences
Published: October 02, 2025
Advancing Brain Targeting: Cost-Effective Surface-Modified Nanoparticles for Faster Market Entry.
Journal: Pharmaceutics
Published: April 09, 2025
Could encapsulation of natural compounds in BBB-permeable nanocarriers produce effective Alzheimer's disease treatments?
Journal: Nanomedicine (London, England)
Published: December 27, 2024
A small TAT-TrkB peptide prevents BDNF receptor cleavage and restores synaptic physiology in Alzheimer's disease.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: December 13, 2024
Folic-Acid-Conjugated Poly (Lactic-Co-Glycolic Acid) Nanoparticles Loaded with Gallic Acid Induce Glioblastoma Cell Death by Reactive-Oxygen-Species-Induced Stress.
Journal: Polymers
Published: July 02, 2024
A small TAT-TrkB peptide prevents BDNF receptor cleavage and restores synaptic physiology in Alzheimer's disease.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: January 20, 2024
Last Updated: 09/26/2026